12:00 AM
 | 
Sep 08, 2008
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Seven-day contraceptive patch: Phase II data

Top-line data from an open-label, cross-over pharmacokinetic study in 39 patients showed that AG-200-15 produced EE and LNG levels that were less than with oral...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >